MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Exelixis Shares 2011-2025 | EXEL
Annual Shares Exelixis
| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 290 M | 318 M | 322 M | 315 M | 303 M | 303 M | 298 M | 294 M | 209 M | 209 M | 194 M | 184 M | 160 M | 126 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 322 M | 126 M | 252 M |
Quarterly Shares Exelixis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 268 M | 273 M | 279 M | 282 M | 286 M | 289 M | 301 M | 303 M | 315 M | 324 M | 324 M | 324 M | 322 M | 321 M | 320 M | 319 M | 315 M | 314 M | 312 M | 305 M | 309 M | 308 M | 305 M | - | 303 M | 302 M | 301 M | 300 M | 298 M | 297 M | 296 M | 296 M | 294 M | 293 M | 291 M | 290 M | 256 M | 229 M | 228 M | 228 M | 218 M | 196 M | 196 M | 196 M | 195 M | 195 M | 192 M | 185 M | 184 M | 184 M | 184 M | 184 M | 166 M | 149 M | 142 M | 136 M | 129 M | 136 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 324 M | 129 M | 256 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
166 M | $ 4.85 | 2.87 % | $ 805 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
77.3 M | $ 3.21 | -1.23 % | $ 248 M |  USA |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | USA |
 |
Aptevo Therapeutics
APVO
|
276 K | $ 1.06 | -6.64 % | $ 293 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
54.8 M | $ 215.41 | -2.27 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.15 | -3.85 % | $ 7.58 B |  Australia |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
BioVie
BIVI
|
1.48 M | $ 1.43 | -1.39 % | $ 2.11 M | USA |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.21 B | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
244 M | $ 94.02 | -0.84 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
60.3 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
48.4 M | $ 26.2 | 3.68 % | $ 1.27 B | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
14.7 M | $ 9.59 | 0.31 % | $ 141 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.18 B | $ 0.27 | -6.08 % | $ 588 M |  Israel |
 |
Arena Pharmaceuticals
ARNA
|
60.8 M | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | USA |
 |
Catalyst Biosciences
CBIO
|
65.8 M | $ 13.48 | -4.36 % | $ 887 M | USA |
 |
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
75.7 M | $ 549.1 | -2.69 % | $ 41.6 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
6.28 M | $ 2.4 | 4.34 % | $ 15.1 M | USA |
 |
AstraZeneca PLC
AZN
|
1.42 B | $ 91.04 | 1.35 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
5.39 M | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 8.87 | -1.55 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
1.37 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
64.7 M | $ 11.23 | -2.69 % | $ 726 M | USA |
 |
Biogen
BIIB
|
146 M | $ 174.94 | 0.48 % | $ 25.5 B | USA |
 |
Abeona Therapeutics
ABEO
|
21.4 M | $ 5.07 | -5.5 % | $ 108 M | USA |
 |
Celldex Therapeutics
CLDX
|
64.4 K | $ 27.11 | -1.47 % | $ 1.75 M | USA |
 |
ADiTx Therapeutics
ADTX
|
13.2 K | $ 1.66 | -25.84 % | $ 21.9 K | USA |
 |
Cellectar Biosciences
CLRB
|
12.2 M | $ 3.36 | -7.32 % | $ 41.1 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
30.8 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
301 M | - | - | - | Russia |